Poradosu Enrique 4
4 · Nuvectis Pharma, Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Poradosu Enrique
Chief Science & Business Off
Transactions
- Award
Common Stock
2022-04-01+60,000→ 1,257,649 total
Footnotes (2)
- [F1]The restricted stock units will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025.
- [F2]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.